AMSTERDAM, May 9, 2016 /PRNewswire/ -- Royal
Philips (NSYE: PHG, AEX: PHIA) today announced that it will
showcase the company's latest developments in Magnetic Resonance
(MR) solutions and open innovation toolsets at the International
Society for Magnetic Resonance in Medicine's (ISMRM)
24th Annual Meeting & Exhibition in
Singapore.
Visitors to Philips' booth #115 will see the latest
innovations designed to unlock the full potential of MRI and bring
better care to more people at lower cost. To enable this, Philips
will highlight how to make MR research more accessible to its
research partners. MR-Paradise, the company's open innovation
toolset, is designed to give Philips' researchers using MR
technology the ability to expand the limits of research in MR and
to help speed the translation from discovery to clinical
practice.
"At Philips, we have a long history of converting research into
meaningful innovation to improve lives," said Eric Jean, General Manager of MRI, Philips. "We
look beyond the current technology to the experiences of the people
at the heart of care – patients, clinicians and caregivers – to
unlock insights across the patient journey. At this year's ISMRM,
we are excited to share stories on how our MR open innovation tools
and collaborations have helped our customers, partners and care
teams across the health continuum."
Leveraging Philips' user community, the open research platform
allows for ideas and knowledge to be shared among others who are
pushing the boundaries of MR methods and applications. Philips'
integrated solutions highlight the commitment to open and
collaborative innovation in MR.
"As a user of Philips' MR systems, the University of Kumamoto
has a high level of trust in Philips' technical and clinical
understanding," said Dr. Tetsuya
Yoneda, Associate Professor in the Department of Medical
Physics at Kumamoto University in Japan. "It was a logical next step to
collaborate with Philips to advance techniques such as SWIp
developed for susceptibility weighted imaging to detect indicators
of neuro vascular diseases. The SWIp method is now routinely used
in neuro examinations at hospitals around the world, and through
our partnership with Philips and access to their open innovation
tools, we are working to enhance these techniques and extend its
scope."
This year, Philips' ISMRM exhibit will also feature the
following new solutions and technologies:
- ScanWise Implant – Recently 510(k) cleared, this
MRI-guided user interface and automatic scan parameter selection
helps simplify the scanning of patients with MR Conditional
implants, streamlining exams and supporting diagnostic confidence
of this growing patient population.
- mDIXON XD – Delivers fast, improved sharpness*,
fat-suppression MR imaging to help visualize abnormalities that
otherwise could be obscured by fat, increasing clinical information
by providing two contrasts in a single scan.
- Ingenia MR-RT – Meets specific radiation therapy (RT)
needs by providing high-quality MR images acquired in the RT
treatment position. As part of its Ingenia MR-RT platform, Philips'
MRCAT (Magnetic Resonance for Calculating ATtenuation) for prostate
cancer treatment recently received 510(k) clearance from the Food
and Drug Administration.
*Fat-free TSE imaging with fat-shift correction for improved
sharpness and increased SNR compared to a standard non-fat-shift
corrected fat-free TSE approach.
For more information on Philips' integrated MR solutions, and to
learn more about presence at ISMRM, www.philips.com/ismrm and
follow the conversation on @PhilipsLiveFrom. In addition,
Dr. Tetsuya Yoneda's video on the
benefits of working with Philips, can be viewed here.
For further information, please contact:
Adrienne Smith
Philips Diagnostic Imaging
Tel: +1 781-277-1170
Email: Adrienne.Smith@philips.com
Kathy O'Reilly
Philips Group Communications
Tel: +1 978-221-8919
Email: Kathy.oreilly@philips.com
@kathyoreilly
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a
leading health technology company focused on improving
people's health and enabling better outcomes across
the health continuum from healthy living and prevention, to
diagnosis, treatment and home care. Philips leverages advanced
technology and deep clinical and consumer insights to
deliver integrated solutions. The company is a leader in
diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as
in consumer health and home care. Philips'
wholly owned subsidiary Philips Lighting is the
global leader in lighting products, systems and
services. Headquartered in the
Netherlands, Philips posted 2015 sales of EUR 24.2 billion and employs approximately
104,000 employees with sales and services in more than 100
countries. News about Philips can be found at
www.philips.com/newscenter.
Logo -
http://photos.prnewswire.com/prnh/20140122/NE50581LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/philips-will-showcase-how-to-advance-research-collaborations-through-open-innovation-at-the-ismrm-2016-annual-meeting-300264577.html
SOURCE Royal Philips